NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc
Abstract Diffuse large B-cell lymphoma (DLBCL) is malignant hyperplasia of B lymphocytes and standard care cannot satisfactorily meet clinical needs. Potential diagnostic and prognostic DLBCL biomarkers are needed. NCBP1 could bind to the 5ʹ-end cap of pre-mRNAs to participate in RNA processing, tra...
Main Authors: | Sibo Meng, Yuan Xia, Mingying Li, Yuyan Wu, Dongmei Wang, Ying Zhou, Daoxin Ma, Jingjing Ye, Tao Sun, Chunyan Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-35777-2 |
Similar Items
-
HDAC1/3-dependent moderate liquid–liquid phase separation of YY1 promotes METTL3 expression and AML cell proliferation
by: Meng Li, et al.
Published: (2022-11-01) -
The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF
by: Yingying Cheng, et al.
Published: (2020-08-01) -
An NCBP3-Domain Protein Mediates Meiotic Silencing by Unpaired DNA
by: Erin C. Boone, et al.
Published: (2020-06-01) -
Clinicopathological analysis of DLBCL/HGBL with MYC, BCL2 and BCL6 gene rearrangement
by: WEI Jing, HE Yaqi, XUE Tian, BAI Qianming, SHUI Ruohong, LU Hongfen, LI Xiaoqiu, YU Baohua
Published: (2023-09-01) -
The m<sup>7</sup>G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling
by: Jiancong Xie, et al.
Published: (2023-11-01)